SPRB Company Profile and Key Details
Spruce Biosciences, Inc.
SPRB Stock Price Chart
Stock Price Today
Spruce Biosciences, Inc. (SPRB) stock declined over -0.37%, trading at $0.38 on NASDAQ, down from the previous close of $0.38. The stock opened at $0.38, fluctuating between $0.37 and $0.39 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.
Company Information
| Employees | 29 |
| Beta | 2.37 |
| Sales or Revenue | $10.09M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Spruce Biosciences, Inc. (NASDAQ: SPRB) stock price is $0.38 in the last trading session. During the trading session, SPRB stock reached the peak price of $0.39 while $0.37 was the lowest point it dropped to. The percentage change in SPRB stock occurred in the recent session was -0.37% while the dollar amount for the price change in SPRB stock was -$0.00.
The NASDAQ listed SPRB is part of Biotechnology industry that operates in the broader Healthcare sector. Spruce Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Libbie Mansell M.B.A., Ph.D.
Chief Regulatory & Quality Officer
Dr. Ralph William Charlton III, M.D.
Chief Medical Officer
Ms. P. J. Ramtin
Senior Vice President of Bus. Operations
Dr. Mojtaba Noursalehi Ph.D.
Senior Vice President of Biometrics
Dr. Javier Szwarcberg M.D., M.P.H.
Chief Executive Officer & Director
Mr. Samir M. Gharib CPA, CPA, M.B.A.
Pres & Chief Financial Officer
SPRB's closing price is 11.67% higher than its 52-week low of $0.34 where as its distance from 52-week high of $5.95 is -93.58%.
Number of SPRB employees currently stands at 29.
Official Website of SPRB is: https://www.sprucebiosciences.com
SPRB could be contacted at phone 415 655 4168 and can also be accessed through its website. SPRB operates from 2001 Junipero Serra Boulevard, Daly City, CA 94014, United States.
SPRB stock volume for the day was 137.81K shares. The average number of SPRB shares traded daily for last 3 months was 588.71K.
The market value of SPRB currently stands at $15.77M with its latest stock price at $0.38 and 41.3M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com